Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer

The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer

(2021) Jaime A. Pardo et al.   ANNALS OF SURGICAL ONCOLOGY

The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer

(2021) Roberto A. Leon-Ferre et al.   ANNALS OF SURGICAL ONCOLOGY

Response in breast vs axilla after neoadjuvant treatment and implications for nonoperative management of invasive breast cancer

(2021) Hank Schmidt et al.   Breast Journal

Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy

(2021) Elizabeth J. Sutton et al.   JAMA Network Open

Treatment response correlation between primary tumor and axillary lymph nodes after neoadjuvant therapy in breast cancer: a retrospective study based on real-world data

(2021) Yu Wang et al.   Gland Surgery

Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease

(2021) Neha Goel et al.   JOURNAL OF SURGICAL ONCOLOGY

Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease

(2021) Sanaz Samiei et al.   JAMA Surgery

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

(2020) Kimberly H. Allison et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

(2020) Han-Byoel Lee et al.   BREAST CANCER RESEARCH AND TREATMENT

Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy

(2020) Joerg Heil et al.   ANNALS OF SURGERY

Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?

(2020) Amparo Garcia-Tejedor et al.   BREAST CANCER RESEARCH AND TREATMENT

Accuracy of Post–Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer

(2020) Marios Konstantinos Tasoulis et al.   JAMA Surgery

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

(2020) Ariane A. van Loevezijn et al.   ANNALS OF SURGICAL ONCOLOGY

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

(2019) Hee Jun Choi et al.   BREAST CANCER RESEARCH AND TREATMENT

Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques

(2019) Jennifer M. Racz et al.   ANNALS OF SURGICAL ONCOLOGY

Neo‐adjuvant chemotherapy and axillary de‐escalation management for patients with clinically node‐negative breast cancer

(2019) Zhi‐qiang Shi et al.   Breast Journal

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

(2018) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status

(2018) Guusje Vugts et al.   Breast Journal

Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy

(2018) Alison U. Barron et al.   JAMA Surgery

Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy

(2018) Sanaz Samiei et al.   ANNALS OF SURGERY

Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

(2018) Alison M. Pease et al.   ANNALS OF SURGICAL ONCOLOGY

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

(2018) Gunter von Minckwitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

(2017) Norikazu Masuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

(2017) Audree B. Tadros et al.   JAMA Surgery

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

(2015) Jean-Francois Boileau et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY